Biohaven Pharmaceuticals Inc.
- Address
- 215 Church Street
Sponsor Overview
Specializations
Psychiatric Disorders
Biohaven Pharmaceuticals Inc. is active in clinical research for Obsessive Compulsive Disorder, with studies centered on patients who have not responded adequately to standard SSRI and related antidepressant treatments.
- Obsessive Compulsive Disorder
- Treatment-resistant symptoms
- Adjunctive therapy
The sponsor’s psychiatric research includes evaluation of symptom improvement and longer-term safety and tolerability in individuals living with persistent compulsive and intrusive symptoms.
Neuromuscular Disease
Biohaven also supports research in Spinal Muscular Atrophy, focusing on functional outcomes in participants receiving established disease-modifying treatments such as nusinersen and risdiplam.
- Spinal Muscular Atrophy
- Motor function
- Neuromuscular impairment
These studies examine changes in physical performance and mobility-related measures in a chronic motor neuron disorder.
Central Nervous System Therapeutics
The sponsor’s portfolio reflects interest in central nervous system conditions where persistent symptoms affect daily functioning and quality of life, particularly in neuropsychiatric and neurologic disease settings.
- Neuropsychiatric disorders
- Neurologic disorders
- Functional outcome assessment
Research activity spans symptom control, functional change, and treatment response in disorders with substantial unmet medical need.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Spinal Muscular Atrophy Patients on Stable Nusinersen/Risdiplam Regimen |  Belgium Czechia Germany Italy Poland Spain The Netherlands | Not Recruiting |
| Evaluation of Troriluzole as Adjunctive Therapy in Patients with Obsessive Compulsive Disorder with Inadequate Response to Standard Treatment | Italy Spain | Not Recruiting |
| Long-Term Safety Evaluation of Adjunctive Troriluzole in Patients with Obsessive Compulsive Disorder Unresponsive to SSRI, Clomipramine, Venlafaxine, or Desvenlafaxine | Italy Spain | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 27 sites across their trial portfolio.
Therapeutic Focus
- 1.Behavioral Disciplines and Activities2 trials20 other sponsors
- 2.Musculoskeletal Diseases1 trial238 other sponsors
Partnered Research Centres
27 centres- Address
- Via Giovanni Battista Grassi 74, 20157 Milan
- Address
- Via Sergio Pansini 5, 80131 Naples
- Address
- Regione Gonzole 10, 10043 Orbassano
- Address
- Via Altura 3, 40139 Bologna
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- Piazza Dell'ospedale Maggiore 3, 20162 Milan
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Biohaven Pharmaceuticals Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.